Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
about
Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?Emerging role of Toll-like receptor 4 in hepatocellular carcinomaMyeloid differentiation primary response gene 88-leukotriene B4 receptor 2 cascade mediates lipopolysaccharide-potentiated invasiveness of breast cancer cellsSynergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinomaDownregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice.TIFA, an inflammatory signaling adaptor, is tumor suppressive for liver cancer.Effects of TLR4 gene silencing on the proliferation and apotosis of hepatocarcinoma HEPG2 cells.Functional RIG-I-like receptors control the survival of mesenchymal stem cellsNovel chemokine-like activities of histones in tumor metastasis.Toll-like receptor-4 modulation for cancer immunotherapy.Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling.Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.Plasma lipopolysaccharide-binding protein and colorectal cancer risk: a nested case-control study in the Multiethnic Cohort.NADPH oxidase 4 modulates hepatic responses to lipopolysaccharide mediated by Toll-like receptor-4.Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression.Activation of the TLR4/MyD88 signaling pathway contributes to the development of human hepatocellular carcinoma via upregulation of IL-23 and IL-17A.Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model.
P2860
Q26770029-4F526360-7777-4564-804F-91D34C30EB33Q26824613-5B6CA50A-ABC1-4847-96E6-DA851070FC86Q28257239-46824036-7A94-4041-B7CC-CD3A55718B53Q33618658-2188D2AC-9468-4873-9DFA-79957C52A783Q35826547-914780B0-87D6-438F-80C5-2BF55482527CQ36105484-B6CCFD12-F572-46C7-943A-C618526C2EB6Q36245950-7429BC4B-1A7F-46CC-92A5-A80A5CC9FD0BQ36825783-0D107F83-406E-4AE2-A8BE-D8134FD23FDCQ37424134-18993F17-6631-40D5-B5AA-2A169DF5A0AFQ37641674-FB4AA207-DEFD-464A-AAE2-B816C11908A3Q38239659-555BE1AA-79D3-429E-89B0-810C75818A4DQ38620883-462C2D8A-FFD4-4583-8300-409C9CE972E8Q40880190-6F6F0C92-0F7E-4C7C-952F-47C0738CB2A4Q45946381-791D087D-7C78-4635-B3D6-D6D20C8D7DB5Q46024987-99543954-A02D-4EF9-812B-F49F24565881Q46066238-E6DBEE99-362C-4590-92BD-0E141B9B7B22Q49255236-C35439F8-A6BE-4445-A4BC-E159C1AB5C7EQ51653926-9C412C74-30C1-4564-BBA6-4A3CDB4FC687Q52659166-469063E9-FACB-41BD-99E2-FEC83BDDE7E6Q52730051-7DBB52CD-1505-41CF-8852-518069366E7FQ55025651-B30D3CD5-9400-48F7-BBDB-3EF8A0413BBAQ55278654-4BAD6C09-D536-4F6A-88D5-369E6A3D6448Q55449343-7E505BE9-BCB6-49E0-9AA7-8E3676DDB882
P2860
Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lipopolysaccharide-induced tol ...... n in hepatocellular carcinoma.
@en
Lipopolysaccharide-induced tol ...... n in hepatocellular carcinoma.
@nl
type
label
Lipopolysaccharide-induced tol ...... n in hepatocellular carcinoma.
@en
Lipopolysaccharide-induced tol ...... n in hepatocellular carcinoma.
@nl
prefLabel
Lipopolysaccharide-induced tol ...... n in hepatocellular carcinoma.
@en
Lipopolysaccharide-induced tol ...... n in hepatocellular carcinoma.
@nl
P2093
P2860
P1476
Lipopolysaccharide-induced tol ...... n in hepatocellular carcinoma.
@en
P2093
Haigang Li
Hongguang Zhu
Zhiquan Huang
P2860
P2888
P304
P356
10.1007/S10620-013-2745-3
P577
2013-07-05T00:00:00Z